Filing Details
- Accession Number:
- 0001181431-14-031922
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-15 14:41:46
- Reporting Period:
- 2014-09-15
- Filing Date:
- 2014-09-15
- Accepted Time:
- 2014-09-15 14:41:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1382911 | Orexigen Therapeutics Inc. | OREX | Pharmaceutical Preparations (2834) | 651178822 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380022 | Michael Narachi | C/O Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Court, Suite 200 La Jolla CA 92037 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-15 | 50,000 | $4.78 | 58,026 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Weighted average from 9 transactions with prices ranging from $4.685 to $4.870. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares purchased at each separate price.
- Includes 4,046 shares acquired under the Issuer's Employee Stock Purchase Plan on May 30, 2014.
Billionaire Hedge Funds
